NCT07279272Completed
The Effect of the Human Regenerator Jet Device on the Quality of Life of Adult Individuals [HR-QoL]
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
This cross-over single-blinded study aims to evaluate the effect of a novel cold atmospheric plasma jet-producing device, the Human Regenerator Power Jet device, for individuals who suffer from chronic stress, chronic pain, chronic fatigue, sleep disorders, and Post-COVID/Long-COVID Syndrome, all conditions that affect the QoL among adults in Greece and worldwide.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 18 Nov 2025
- Start date
- 9 Jul 2024
- Primary completion date
- 22 Jul 2025
- Lead sponsor
- University of Athens
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT07279272
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 9 Jul 2024 to the primary completion date, 22 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with major psychiatric disorders
Other
- Pregnancy or Breast-feeding period
- Participation on another Stress related study
- Patients with implanted devices
- Refusal to participate in the study
Age in the registry: 18 years to 94 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Endocrine Unit of the University of Athens Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.